Chimera Investment Corp's income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 31, 2025 · FY), Chimera Investment Corp reported net income of $230.5M (+30.9% year on year).
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Interest income | $821.3M | $761.0M | $772.9M | $773.1M |
| Interest expense | $554.9M | $496.3M | $509.5M | $333.3M |
| Net interest income | $266.4M | $264.7M | $263.4M | $439.8M |
| Increase in provision for credit losses | $15.7M | $9.8M | $11.4M | $7.0M |
| Net unrealized gains (losses) on derivatives | $10.4M | $3.0M | ($6.4M) | ($1.5M) |
| Realized losses on derivatives | ($33.4M) | ($21.5M) | ($41.0M) | — |
| Periodic interest on derivatives, net | $20.4M | $23.8M | $17.2M | ($1.8M) |
| Net gains (losses) on derivatives | ($2.6M) | $5.2M | ($30.2M) | ($3.8M) |
| Investment management and advisory fees | $35.4M | $2.7M | — | — |
| Interest income from investment in MSR financing receivables | $520.0K | — | — | — |
| Net unrealized gains on financial instruments at fair value | $81.7M | $10.8M | $34.4M | ($736.9M) |
| Net realized losses on sales of investments | ($23.2M) | ($5.2M) | ($31.2M) | ($76.5M) |
| Gains on extinguishment of debt | $2.1M | $0 | $3.9M | ($2.9M) |
| Other investment gains | $5.7M | $9.5M | $1.1M | ($1.9M) |
| Gain on origination and sale of loans, net | $20.6M | — | — | — |
| Total other income (losses) | $120.3M | $23.0M | ($22.1M) | ($821.9M) |
| Compensation and benefits | $56.7M | $41.4M | $30.6M | $49.4M |
| General and administrative expenses | $30.0M | $23.2M | $25.1M | $22.7M |
| Servicing and asset manager fees | $27.7M | $29.8M | $32.6M | $36.0M |
| Amortization of intangibles and depreciation expenses | $7.2M | $321.0K | — | — |
| Transaction expenses | $16.6M | $7.1M | $15.4M | $16.1M |
| Total other expenses | $138.3M | $101.8M | $103.7M | $124.2M |
| Income before income taxes | $232.8M | $176.1M | $126.2M | ($513.3M) |
| Income tax expense | $2.3M | $49.0K | $102.0K | ($253.0K) |
| Net income | $230.5M | $176.1M | $126.1M | ($513.1M) |
| Dividends on preferred stock | $86.0M | $85.7M | $73.8M | $73.8M |
| Net income available to common shareholders | $144.5M | $90.3M | $52.4M | ($586.8M) |
| Basic (in dollars per share) | $1.76 | $1.12 | $0.23 | -$2.51 |
| Diluted (in dollars per share) | $1.72 | $1.10 | $0.23 | -$2.51 |
| Basic (in shares) | 82.2M | 81.0M | 230.1M | 233.9M |
| Diluted (in shares) | 83.9M | 82.2M | 232.6M | 233.9M |
| Line item | Jun 30, 2026 · Q2 | Mar 31, 2026 · Q1 | Sep 30, 2025 · Q3 | Jun 30, 2025 · Q2 |
|---|---|---|---|---|
| Interest income | $221.6M | $219.3M | $209.1M | $201.3M |
| Interest expense | $151.1M | $144.3M | $144.1M | $135.3M |
| Net interest income | $70.5M | $75.0M | $65.0M | $66.0M |
| Increase in provision for credit losses | $7.2M | $2.8M | $2.6M | $4.4M |
| Net unrealized gains (losses) on derivatives | $15.4M | $18.1M | ($7.9M) | ($2.6M) |
| Realized gains (losses) on derivatives | $9.5M | $2.9M | $2.0M | ($18.0M) |
| Periodic interest on derivatives, net | $2.1M | $1.8M | $5.8M | $5.1M |
| Net gains (losses) on derivatives | $27.0M | $22.9M | ($141.0K) | ($15.4M) |
| Investment management and advisory fees | $6.5M | $7.2M | $8.5M | $8.8M |
| Interest income from investment in MSR financing receivables | $838.0K | $2.3M | $500.0K | — |
| Net unrealized gains (losses) on financial instruments at fair value | ($43.4M) | ($37.5M) | ($37.0M) | $7.0M |
| Net realized gains (losses) on sales of investments | ($9.6M) | ($40.4M) | $2.0M | ($1.9M) |
| Gains (losses) on extinguishment of debt | ($2.7M) | ($38.9M) | $0 | $0 |
| Other investment gains (losses) | $1.2M | ($910.0K) | $1.9M | $3.0M |
| Gain on origination and sale of loans, net | $22.2M | $21.4M | — | — |
| Total other income (losses) | $2.0M | ($64.0M) | ($24.2M) | $1.4M |
| Compensation and benefits | $25.1M | $26.7M | $13.8M | $11.7M |
| General and administrative expenses | $11.5M | $12.2M | $6.9M | $6.8M |
| Servicing and asset manager fees | $4.4M | $5.5M | $7.0M | $7.3M |
| Depreciation, amortization, and impairment of intangible assets | $4.1M | $9.6M | — | — |
| Transaction expenses | $3.2M | $98.0K | $9.9M | $390.0K |
| Total other expenses | $48.3M | $54.1M | $38.6M | $27.1M |
| Income (loss) before income taxes | $17.1M | ($46.0M) | ($329.0K) | $35.9M |
| Income tax (benefit) expense | ($301.0K) | ($2.1M) | $251.0K | $409.0K |
| Net income (loss) | $17.4M | ($43.9M) | ($580.0K) | $35.5M |
| Dividends on preferred stock | $21.4M | $21.1M | $21.4M | $21.4M |
| Net income (loss) available to common shareholders | ($4.0M) | ($65.0M) | ($22.0M) | $14.0M |
| Basic (in dollars per share) | -$0.05 | -$0.78 | -$0.27 | $0.17 |
| Diluted (in dollars per share) | -$0.05 | -$0.78 | -$0.27 | $0.17 |
| Basic (in shares) | 83.8M | 83.7M | 81.5M | 81.4M |
| Diluted (in shares) | 83.8M | 83.7M | 81.5M | 82.6M |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Cash and cash equivalents | $278.6M | $84.0M | $221.7M | $264.6M |
| Non-Agency RMBS, at fair value (net of allowance for credit losses of $43 million and $28 million, respectively) | $817.3M | $1.1B | $1.0B | $1.1B |
| Agency MBS, at fair value | $3.5B | $519.2M | $102.5M | — |
| Loans held for investment, at fair value | $9.8B | $11.2B | $11.4B | $11.4B |
| Loans held-for-sale, at fair value | $896.1M | — | — | — |
| Accrued interest receivable | $78.7M | $81.4M | $77.0M | $61.8M |
| Other assets | $408.3M | $170.9M | $87.0M | $133.9M |
| Interests in MSR financing receivables | $37.3M | — | — | — |
| Derivatives, at fair value, net | $25.2M | $117.0K | $0 | $4.1M |
| Total assets | $15.8B | $13.1B | $12.9B | $13.4B |
| Secured financing agreements ($7.4 billion and $4.1 billion pledged as collateral, respectively, and includes $299 million and $319 million at fair value, respectively) | $6.0B | $2.8B | $2.4B | $3.4B |
| Securitized debt, collateralized by Non-Agency RMBS ($210 million and $229 million pledged as collateral, respectively) | $66.6M | $71.2M | $75.0M | $78.5M |
| Securitized debt at fair value, collateralized by Loans held for investment ($9.4 billion and $10.2 billion pledged as collateral, respectively) | $6.7B | $7.0B | $7.6B | $7.1B |
| Long term debt | $251.5M | $134.6M | — | — |
| Payable for investments purchased | $3.3M | $454.7M | $158.9M | $9.3M |
| Accrued interest payable | $43.0M | $41.5M | $38.3M | $30.7M |
| Dividends payable | $34.9M | $34.3M | $54.6M | $64.5M |
| Accounts payable and other liabilities | $82.3M | $45.1M | $9.4M | $16.6M |
| Derivatives, at fair value, net | $1.8M | — | — | — |
| Total liabilities | $13.2B | $10.6B | $10.4B | $10.7B |
| Preferred Stock, par value of $0.01 per share, 100,000,000 shares authorized: | $372000.00 | $372000.00 | $372000.00 | $372000.00 |
| Common stock: par value $0.01 per share; 166,667,667 shares authorized, 80,472,622 and 80,453,552 shares issued and outstanding, respectively | $834000.00 | $809000.00 | $2414000.00 | $2318000.00 |
| Additional paid-in-capital | $4.4B | $4.4B | $4.4B | $4.3B |
| Accumulated other comprehensive income | $146.3M | $159.4M | $185.7M | $229.3M |
| Cumulative earnings | $4.6B | $4.3B | $4.2B | $4.0B |
| Cumulative distributions to stockholders | ($6.6B) | ($6.4B) | ($6.2B) | ($5.9B) |
| Total stockholders' equity | $2.6B | $2.5B | $2.6B | $2.7B |
| Total liabilities and stockholders' equity | $15.8B | $13.1B | $12.9B | $13.4B |
| Line item | Jun 30, 2026 | Mar 31, 2026 | Sep 30, 2025 | Jun 30, 2025 |
|---|---|---|---|---|
| Cash and cash equivalents | $444.0M | $476.2M | $491.5M | $250.2M |
| Non-Agency RMBS, at fair value (net of allowance for credit losses of $53 million and $43 million, respectively) | $727.6M | $756.1M | $868.8M | $1.0B |
| Agency MBS, at fair value | $5.3B | $5.2B | $2.9B | $2.7B |
| Loans held for investment, at fair value | $7.9B | $8.2B | $10.3B | $10.6B |
| Loans held-for-sale, at fair value | $1.1B | $700.6M | — | — |
| Accrued interest receivable | $76.4M | $76.4M | $72.2M | $74.6M |
| Other assets | $430.0M | $438.6M | $213.4M | $211.8M |
| Interests in MSR financing receivables | $35.5M | $39.8M | $35.5M | — |
| Derivatives, at fair value, net | $49.6M | $35.5M | $2.1M | $0 |
| Total assets | $16.0B | $16.0B | $15.1B | $14.9B |
| Secured financing agreements ($8.6 billion and $7.4 billion pledged as collateral, respectively, and includes $284 million and $299 million at fair value, respectively) | $7.7B | $7.0B | $4.9B | $4.6B |
| Securitized debt, collateralized by Non-Agency RMBS ($195 million and $210 million pledged as collateral, respectively) | $63.9M | $65.0M | $67.6M | $68.3M |
| Securitized debt at fair value, collateralized by Loans held for investment ($7.5 billion and $9.4 billion pledged as collateral, respectively) | $5.4B | $5.4B | $7.0B | $7.0B |
| Long term debt | $252.6M | $252.0M | $251.0M | $135.2M |
| Payable for investments purchased | $0 | $611.5M | $193.4M | $387.9M |
| Accrued interest payable | $41.6M | $36.6M | $38.0M | $40.8M |
| Dividends payable | $42.0M | $41.0M | $35.4M | $34.6M |
| Accounts payable and other liabilities | $95.5M | $92.1M | $53.6M | $37.7M |
| Derivatives, at fair value, net | $0 | $0 | $5.4M | $301.0K |
| Total liabilities | $13.6B | $13.5B | $12.5B | $12.2B |
| Preferred Stock, par value of $0.01 per share, 100,000,000 shares authorized: | $372000.00 | $372000.00 | $372000.00 | $372000.00 |
| Common stock: par value $0.01 per share; 166,666,667 shares authorized, 83,711,380 and 83,402,145 shares issued and outstanding, respectively | $837000.00 | $836000.00 | $811000.00 | $810000.00 |
| Additional paid-in-capital | $4.4B | $4.4B | $4.4B | $4.4B |
| Accumulated other comprehensive income | $129.0M | $137.7M | $149.4M | $152.4M |
| Cumulative earnings | $4.5B | $4.5B | $4.5B | $4.5B |
| Cumulative distributions to stockholders | ($6.7B) | ($6.6B) | ($6.5B) | ($6.5B) |
| Total stockholders’ equity | $2.4B | $2.5B | $2.6B | $2.6B |
| Total liabilities and stockholders’ equity | $16.0B | $16.0B | $15.1B | $14.9B |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Net income | $230.5M | $176.1M | $126.1M | ($513.1M) |
| (Accretion) Amortization of investment discounts/premiums, net | ($24.7M) | $4.9M | $16.3M | $61.5M |
| Accretion of deferred financing costs, debt issuance costs, and Securitized debt discounts/premiums, net | $18.6M | $13.8M | $31.8M | ($258.0K) |
| Net unrealized (gains) losses on derivatives | ($10.4M) | ($3.0M) | $6.4M | $1.5M |
| Proceeds (payments) for derivative settlements | $0 | $14.5M | ($20.5M) | ($6.2M) |
| Margin (paid) received on derivatives | ($69.9M) | ($10.2M) | $70.4M | ($40.2M) |
| Net unrealized (gains) losses on financial instruments at fair value | ($81.7M) | — | — | — |
| Net realized losses (gains) on sales of investments | $23.2M | $5.2M | $31.2M | $76.5M |
| Other investment (gains) losses | ($5.7M) | ($9.5M) | ($1.1M) | $1.9M |
| Net increase in provision for credit losses | $15.7M | $9.9M | $11.4M | $7.0M |
| Amortization of intangibles and depreciation expenses | $7.2M | $321.0K | — | — |
| Gain on origination and sale of loans, net | $1.2M | — | — | — |
| (Gain) loss on extinguishment of debt | ($2.1M) | $0 | ($3.9M) | $2.9M |
| Equity-based compensation expense | $9.7M | $10.1M | $9.6M | $8.2M |
| Non-cash imputed compensation related to business acquisition | $1.4M | $10.3M | — | — |
| Direct loan origination costs, net | ($1.0B) | — | — | — |
| Sales, settlements and proceeds from sale of loans held-for-sale | $671.6M | — | — | — |
| Fair Value adjustment on mortgage loans held-for-sale | ($7.8M) | — | — | — |
| (Increase) decrease in accrued interest receivable, net | $6.6M | ($4.4M) | ($15.2M) | $7.7M |
| Decrease (increase) in other assets | $11.8M | ($14.5M) | ($15.2M) | ($33.5M) |
| (Decrease) increase in accounts payable and other liabilities | ($5.6M) | $9.5M | ($7.3M) | $5.0M |
| Increase in accrued interest payable, net | ($719.0K) | $3.6M | $7.6M | $9.9M |
| Net cash (used in) provided by operating activities | ($248.9M) | $205.7M | $213.3M | $325.7M |
| Purchases | ($4.2B) | ($1.2B) | ($6.0M) | ($80.9M) |
| Sales | $1.5B | $569.4M | $315.7M | $65.6M |
| Principal payments | $1.8B | $1.5B | $1.5B | $2.6B |
| Payments to acquire businesses | ($183.0M) | ($29.1M) | — | — |
| Purchases | ($441.4M) | ($656.6M) | ($1.3B) | ($2.1B) |
| Payments on purchases of investment in MSR financing receivables | ($38.2M) | — | — | — |
| Net cash (used in) provided by investing activities | ($1.7B) | $178.2M | $551.8M | $509.8M |
| Proceeds from secured financing agreements | $54.5B | $30.0B | $29.1B | $37.8B |
| Payments on secured financing agreements | ($51.8B) | ($29.6B) | ($30.1B) | ($37.6B) |
| Payments on repurchase of common stock | $0 | $0 | ($33.1M) | ($48.9M) |
| Proceeds on issuance of common stock | $0 | $0 | $73.8M | — |
| Proceeds from securitized debt borrowings, collateralized by Loans held for investment | $1.0B | $340.1M | $2.2B | $1.1B |
| Payments on securitized debt borrowings, collateralized by Loans held for investment | ($1.5B) | ($1.2B) | ($1.8B) | ($1.8B) |
| Payments on securitized debt borrowings, collateralized by Non-Agency RMBS | ($17.0K) | ($98.0K) | ($53.0K) | ($2.9M) |
| Net proceeds from issuance of unsecured debt | $115.5M | $134.2M | — | — |
| Common dividends paid | ($122.7M) | ($119.1M) | ($195.2M) | ($287.7M) |
| Preferred dividends paid | ($86.0M) | ($104.2M) | ($55.3M) | ($73.8M) |
| Net cash provided by (used in) financing activities | $2.1B | ($521.6M) | ($807.9M) | ($956.7M) |
| Net increase (decrease) in cash, cash equivalents and restricted cash | $200.5M | ($137.7M) | ($42.9M) | ($121.1M) |
| Cash, cash equivalents and restricted cash at beginning of period | $84.0M | $221.7M | $264.6M | $385.7M |
| Cash, cash equivalents and restricted cash at end of period | $284.5M | — | — | — |
| Interest received | $799.4M | $761.4M | $774.1M | $842.4M |
| Line item | Jun 30, 2026 · YTD | Mar 31, 2026 · Q1 | Sep 30, 2025 · YTD | Jun 30, 2025 · YTD |
|---|---|---|---|---|
| Net income (loss) | ($26.5M) | ($43.9M) | $202.2M | $202.7M |
| (Accretion) Amortization of investment discounts/premiums, net | ($17.1M) | ($9.2M) | ($11.1M) | $522.0K |
| Accretion of deferred financing costs, debt issuance costs, and Securitized debt discounts/premiums, net | $8.7M | $4.4M | $12.6M | $7.4M |
| Net unrealized (gains) losses on derivatives | ($33.5M) | ($18.1M) | $16.9M | $9.0M |
| (Payments) proceeds for derivative settlements | $2.5M | $111.0K | $0 | $0 |
| Margin received (paid) on derivatives | $46.8M | $36.9M | ($61.0M) | ($79.9M) |
| Net unrealized (gains) losses on financial instruments at fair value | $80.9M | $37.5M | — | — |
| Net realized losses on sales of investments | $50.1M | $40.4M | ($76.0K) | $1.9M |
| Other investment (gains) losses | ($320.0K) | $910.0K | ($4.5M) | ($2.5M) |
| Net increase in provision for credit losses | $10.0M | $2.8M | $10.4M | $7.8M |
| Depreciation, amortization, and impairment of intangible assets | $13.7M | $9.6M | — | — |
| Gain on origination and sale of loans, net | ($2.8M) | ($1.6M) | — | — |
| (Gain) loss on extinguishment of debt | $41.6M | $38.9M | ($2.1M) | ($2.1M) |
| Equity-based compensation expense | $5.7M | $2.7M | $8.0M | $5.9M |
| Non-cash imputed compensation related to business acquisition | $682.0K | $341.0K | $1.0M | $682.0K |
| Direct loan origination costs, net | ($2.3B) | ($883.5M) | — | — |
| Sales, settlements and proceeds from sale of loans held-for-sale | $2.0B | $1.1B | — | — |
| Fair value adjustment on mortgage loans held-for-sale | $1.3M | $8.3M | — | — |
| Decrease in accrued interest receivable | $2.3M | $2.3M | $9.2M | $6.8M |
| (Decrease) increase in other assets | ($65.5M) | ($67.2M) | ($182.5M) | $26.9M |
| Increase (decrease) in accounts payable and other liabilities | $19.8M | $17.1M | $4.3M | ($9.3M) |
| Decrease in accrued interest payable | ($1.4M) | ($6.2M) | ($3.4M) | ($398.0K) |
| Net cash (used in) provided by operating activities | ($95.9M) | $243.3M | ($96.1M) | $41.4M |
| Purchases | ($2.3B) | ($1.3B) | ($3.3B) | ($1.9B) |
| Sales | $1.8B | $1.2B | $1.2B | $139.9M |
| Principal payments | $975.0M | $446.1M | $1.3B | $840.4M |
| Purchases | ($469.4M) | ($1.8M) | ($439.8M) | ($436.5M) |
| Distributions received from interests in MSR financing receivables | $7.5M | — | — | — |
| Net cash (used in) investing activities | ($1.7M) | $355.7M | ($1.3B) | ($1.4B) |
| Proceeds from secured financing agreements | $34.1B | $15.7B | $38.2B | $21.7B |
| Payments on secured financing agreements | ($32.4B) | ($14.8B) | ($36.2B) | ($20.0B) |
| Proceeds from securitized debt borrowings, collateralized by Loans held for investment | $378.8M | $0 | $1.0B | $780.2M |
| Payments on securitized debt borrowings, collateralized by Loans held for investment | ($1.7B) | ($1.3B) | ($1.2B) | ($903.3M) |
| Payments on securitized debt borrowings, collateralized by Non-Agency RMBS | ($2.0K) | ($1.0K) | ($16.0K) | ($15.0K) |
| Common dividends paid | ($70.0M) | ($32.4M) | ($90.8M) | ($60.8M) |
| Preferred dividends paid | ($42.5M) | ($21.1M) | ($64.2M) | ($42.8M) |
| Net cash provided by (used in) financing activities | $264.4M | ($400.5M) | $1.8B | $1.5B |
| Net increase in cash, cash equivalents and restricted cash | $166.9M | $198.6M | $407.5M | $166.2M |
| Cash, cash equivalents and restricted cash at beginning of period | $284.5M | $284.5M | $84.0M | $84.0M |
| Cash, cash equivalents and restricted cash at end of period | $451.3M | $483.0M | — | — |
| Interest received | $426.1M | $212.5M | $599.1M | $399.2M |
| Interest paid | $288.1M | $146.3M | $391.6M | $250.0M |
| Change in fair value of contingent earn-out liability | $4.3M | ($5.2M) | — | — |
| Payable for investments purchased | $0 | $611.5M | $193.4M | $387.9M |
| Net change in unrealized gain (loss) on available-for-sale securities | ($17.3M) | ($8.6M) | ($10.0M) | ($7.0M) |
Chimera Investment Corp score and earnings-call analysis · All covered companies
Figures as reported in SEC filings. General information, not investment advice.